Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STACK, A. G.
Right arrow Articles by BLOEMBERGEN, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STACK, A. G.
Right arrow Articles by BLOEMBERGEN, W. E.
J Am Soc Nephrol 12:1516-1523, 2001
© 2001 American Society of Nephrology

Prevalence and Clinical Correlates of Coronary Artery Disease among New Dialysis Patients in the United States: A Cross-Sectional Study

AUSTIN G. STACK and WENDY E. BLOEMBERGEN

Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Correspondence to Dr. Austin G. Stack, Kidney Epidemiology and Cost Center, 315 West Huron Street, Suite 240, Ann Arbor, MI 48103. Phone: 734-998-6611; Fax: 734-998-6620; E-mail: astack{at}umich.edu

Abstract. Despite the high prevalence of coronary artery disease (CAD) among patients with end-stage renal disease (ESRD), few studies have identified clinical correlates using national data. The purpose of this study was to determine the prevalence and clinical associations of CAD in a national random sample of new ESRD in the United States in 1996/1997 (n = 4025). Data on demographic characteristics and comorbidities were obtained from the Dialysis Morbidity and Mortality Study, Wave 2. The principal outcome was CAD, defined as the presence of a previous history of CAD, myocardial infarction, or angina, coronary artery bypass surgery, coronary angioplasty, or abnormal coronary angiographic findings. Multivariate logistic regression analysis was used to assess the relationship of conventional factors and proposed uremic factors to the presence of CAD. CAD was present in 38% of patients. Of the total cohort, 17% had a history of myocardial infarction and 23% had angina. Several conventional risk factors, including advancing age, male gender, diabetes mellitus, and smoking, were significantly associated with CAD. Of the proposed uremic factors, lower serum albumin levels but higher residual renal function and higher hematocrit values were significantly associated with the presence of CAD. Vascular comorbid conditions, structural cardiac abnormalities, white race, and geographic location were also strongly correlated with the presence of CAD. This national study suggests that several conventional CAD risk factors may also be risk factors for CAD among the ESRD population. This study identifies nonconventional factors such as serum albumin levels, vascular comorbid conditions, and structural cardiac abnormalities as important disease correlates. Future logitudinal studies are required to explore the relative importance of the relationships observed here.




This article has been cited by other articles:


Home page
JAMAHome page
D. J. de Jager, D. C. Grootendorst, K. J. Jager, P. C. van Dijk, L. M. J. Tomas, D. Ansell, F. Collart, P. Finne, J. G. Heaf, J. De Meester, et al.
Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
JAMA, October 28, 2009; 302(16): 1782 - 1789.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Perez-Garcia, A. Martin-Malo, J. Fort, X. Cuevas, F. Llados, J. Lozano, F. Garcia, and on behalf of all Investigators from the ANSWER stu
Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 578 - 588.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. Russo, L. F. Morrone, S. Brancaccio, P. Napolitano, E. Salvatore, R. Spadola, M. Imbriaco, C. V. Russo, and V. E. Andreucci
Pulse Pressure and Presence of Coronary Artery Calcification
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 316 - 322.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Panzetta, C. Basile, A. Santoro, E. Ancarani, S. Costantini, F. Guarnieri, and G. Verzetti
Diabetics on dialysis in Italy: a nationwide epidemiological study
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3988 - 3995.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. M. de Mattos, A. Siedlecki, R. S. Gaston, G. J. Perry, B. A. Julian, C. E. Kew II, M. H. Deierhoi, C. Young, J. J. Curtis, and A. E. Iskandrian
Systolic Dysfunction Portends Increased Mortality among Those Waiting for Renal Transplant
J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1191 - 1196.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Nishimura, K. Tsukamoto, N. Hasebe, N. Tamaki, K. Kikuchi, and T. Ono
Prediction of Cardiac Death in Hemodialysis Patients by Myocardial Fatty Acid Imaging
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 139 - 145.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. R. Orth and S. I. Hallan
Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C.-Y. Lin, L.-Y. Lin, and P.-C. Chen
Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in patients initiating haemodialysis
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2645 - 2652.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. C.H. Kwan, F. Kronenberg, S. Beddhu, and A. K. Cheung
Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1246 - 1261.
[Full Text] [PDF]


Home page
CJASNHome page
B. B. Newsome, W. M. McClellan, C. S. Coffey, J. J. Allison, C. I. Kiefe, and D. G. Warnock
Survival Advantage of Black Patients with Kidney Disease after Acute Myocardial Infarction
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 993 - 999.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Volkova, W. McClellan, J. M. Soucie, and A. Schoolwerth
Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2202 - 2209.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. S. Parekh, L. Zhang, B. A. Fivush, and M. J. Klag
Incidence of Atherosclerosis by Race in the Dialysis Morbidity and Mortality Study: A Sample of the US ESRD Population
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1420 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Rubinger, N. Revis, A. Pollak, M. H. Luria, and D. Sapoznikov
Predictors of haemodynamic instability and heart rate variability during haemodialysis
Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2053 - 2060.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. H. Kazmi, G. T. Obrador, S. S. Khan, B. J. G. Pereira, and A. T. Kausz
Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis
Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1808 - 1814.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Locatelli, P. Pozzoni, and L. Del Vecchio
Renal Replacement Therapy in Patients with Diabetes and End-Stage Renal Disease
J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S25 - 29.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
P. K.-T. Li, K.-M. Chow, T. Y.-H. Wong, C.-B. Leung, and C.-C. Szeto
Effects of an Angiotensin-Converting Enzyme Inhibitor on Residual Renal Function in Patients Receiving Peritoneal Dialysis: A Randomized, Controlled Study
Ann Intern Med, July 15, 2003; 139(2): 105 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. K. Ganesh, T. Hulbert-Shearon, F. K. Port, K. Eagle, and A. G. Stack
Mortality Differences by Dialysis Modality among Incident ESRD Patients with and without Coronary Artery Disease
J. Am. Soc. Nephrol., February 1, 2003; 14(2): 415 - 424.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. C. Abbott, J. R. Bucci, D. Cruess, A. J. Taylor, and L. Y.C. Agodoa
Graft Loss and Acute Coronary Syndromes after Renal Transplantation in the United States
J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2560 - 2569.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. C. Longenecker, J. Coresh, N. R. Powe, A. S. Levey, N. E. Fink, A. Martin, and M. J. Klag
Traditional Cardiovascular Disease Risk Factors in Dialysis Patients Compared with the General Population: The CHOICE Study
J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1918 - 1927.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. G. Stack
Determinants of Modality Selection among Incident US Dialysis Patients: Results from a National Study
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1279 - 1287.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. M. O'Hare, C.-y. Hsu, P. Bacchetti, and K. L. Johansen
Peripheral Vascular Disease Risk Factors among Patients Undergoing Hemodialysis
J. Am. Soc. Nephrol., February 1, 2002; 13(2): 497 - 503.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP